Skip to main content
. 2022 Mar 3;36(2):1030–1034. doi: 10.21873/invivo.12798

Table I. Clinical characteristics of patients with renal cell carcinoma and inferior vena cava tumour thrombi who received combination treatment with immune checkpoint inhibitors.

graphic file with name in_vivo-36-1031-i0001.jpg

IMDC: International Metastatic renal cell carcinoma Database Consortium; cTMN: tumor, node, metastasis; AE: adverse event; ICI: immune checkpoint inhibitor; irAE: immune-related AE; LN: lymph node.